Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C

Hepatology

Volumn 31, Issue 1, 2000, Pages 230-234

  Wiedmann, Marcus ^a   Liebert, Uwe G ^a   Oesen, Ute ^b   Porst, Heiner ^c   Wiese, Manfred ^d   Schroeder, Sabine ^a   Halm, Ulrich ^a   Mössner, Joachim ^a   Berr, Frieder ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Affil Hospitals Kuchwald Chemnitz   (Germany)

^c Friedrichstadt in Dresden   (Germany)

^d Klinikum St Georg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DELTOID MUSCLE; DRUG EFFECT; DRUG RESPONSE; FEMALE; HEPATITIS C; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VACCINATION;

EID: 0033970794     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310134     Document Type: Article

References (16)

1. Alter M, Mast E. The epidemiology of viral hepatitis in the United States (Review). Gastroenterol Clin North Am 1994;23:437-455.
2. Lee WM. Hepatitis B virus infection (review). New Engl J Med 1997;337:1733-1745.
3. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, Roumeliotou-Karayannis A, Gerin JL, Purcell RH. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987;92:1844-1850.
4. Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, Kaplowitz N, et al. A serologie follow-up of post-vaccinal hepatitis in the United States Army. N Engl J Med 1987:316:965-970.
5. Fattovich G, Gustina G, Schalm S, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, et al. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. HEPATOLOGY 1995;21:77-82.
6. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis (review). New Engl J Med 1997;336:196-204.
7. Zarski JP, Bohn B, Bastie A, PawlotskyJM, Baud M, Bost-Bezeaux F, Tran van Nhieu J, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998;28:27-33.
8. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, Hsieh CC, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991;15:1974-1976.
9. Simonetti RG, Camma C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case control study. Ann Intern Med 1992;116:97-102.
10. Emini EA, Ellis RW, Miller WJ, McAleer WJ, Scolnick EM, Gerety RJ. Production and immunological analysis of recombinant hepatitis B vaccines. J Infect Dis 1986;13(Suppl A):3S-9S.
11. Zuckerman NJ, Zuckerman AJ: Current issues in the immunization against hepatitis A and B. In: Eibl MM, Huber C, Peter HH, Wahn U, eds., Symposium in Immunology VII. Berlin: Springer, 1998:15-23.
12. Carman WF, Zanetti AR, Karayannis P, Water J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-329.
13. Oon CJ, Tan KL, Harrison T, Zuckerman AJ. Natural history of hepatitis B surface antigen mutants in children. Lancet 1994;348:1524.
14. Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, DeVera A, et al. Hepatitis B vaccine in medical staff of dialysis units. Efficacy and subtype cross-protection. N Engl J Med 1982;307:1481-1486.
15. Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Eckenberg DF, Ostrow DG, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. New Engl J Med 1986;315:209-214.
16. Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S. Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet 1991;337:747-750.